Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
DCTHthis companyDelcath Systems, Inc.	$19.38	126.25×	3.25×	4.24×	82.74×	-1005.2%	86.2%	0.8%	3.2%	2.4%	0.5%	5.8%	0.01×	-11.02×	0×	10.92×	0.0%	5	15.11	2	B-
CATXPerspective Therapeutics, Inc.	$0.86	-1.96×	0.98×	0×	-1.74×	-87.1%	0.0%	0.0%	0.0%	-49.8%	-47.2%	-46.9%	0.02×	0.27×	-302.03×	5.17×	0.0%	3	-0.5	3	B-
TLSITriSalus Life Sciences, Inc.	$3.44	-3.79×	-7.81×	5.86×	-8.43×	-3311.9%	84.6%	-59.7%	-86.9%	115.8%	-112.3%	-7.2%	-1.02×	-0.42×	-4.86×	2.8×	0.0%	2	-4.71	1	D+
Peer median	—	-2.88×	-3.42×	2.93×	-5.08×	-1699.5%	42.3%	-29.8%	-43.4%	33.0%	-79.7%	-27.0%	-0.5×	-0.08×	-153.45×	3.99×	0.0%	3	-2.61	2	—